commercialization

The key drivers of increasing market annual growth in Tissue Engineering and Regenerative Medicine includes the increasing awareness about stem cell therapy techniques, proliferate funding for new stem cell lines research and development of advanced genomic methods for  therapeutic purpose. Based on therapy, the Regenerative medicine market is segmented into cell therapy, gene therapy, tissue engineering and immunotherapy. Biotherapies evolved out as anti-cancer agents which include immune system targeted therapies. The cell therapy segment in regenerative medicine is expected to account for the largest share of this growing cell therapy market, increasing funding for further research from several agencies, private organizations support for the research, development of innovative cell therapies, promote the growing inclination of the healthcare industry towards stem cell research and increasing global scientific awareness about the benefits of stem cell therapies.